These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20331911)

  • 41. Impact of APOE epsilon4 on the cognitive performance of a sample of non-demented Puerto Rican nonagenarians.
    Carrión-Baralt JR; Meléndez-Cabrero J; Rodríguez-Ubiñas H; Schmeidler J; Beeri MS; Angelo G; Sano M; Silverman JM
    J Alzheimers Dis; 2009; 18(3):533-40. PubMed ID: 19584451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of CHRNA4 polymorphism with depression and loneliness in elderly males.
    Tsai SJ; Yeh HL; Hong CJ; Liou YJ; Yang AC; Liu ME; Hwang JP
    Genes Brain Behav; 2012 Mar; 11(2):230-4. PubMed ID: 22008229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of extracerebral cholesterol homeostasis and ApoE e4 in cognitive decline.
    van den Kommer TN; Dik MG; Comijs HC; Lütjohann D; Lips P; Jonker C; Deeg DJ
    Neurobiol Aging; 2012 Mar; 33(3):622.e17-28. PubMed ID: 21482441
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic effects on old-age cognitive functioning: a population-based study.
    Laukka EJ; Lövdén M; Herlitz A; Karlsson S; Ferencz B; Pantzar A; Keller L; Graff C; Fratiglioni L; Bäckman L
    Psychol Aging; 2013 Mar; 28(1):262-74. PubMed ID: 23276211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for the modality independence of the genetic epistasis between the dopaminergic and cholinergic system on working memory capacity.
    Markett S; Montag C; Walter NT; Reuter M
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):216-20. PubMed ID: 21130611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Total cholesterol and oxysterols: early markers for cognitive decline in elderly?
    van den Kommer TN; Dik MG; Comijs HC; Fassbender K; Lütjohann D; Jonker C
    Neurobiol Aging; 2009 Apr; 30(4):534-45. PubMed ID: 17888546
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-analysis.
    Wisdom NM; Callahan JL; Hawkins KA
    Neurobiol Aging; 2011 Jan; 32(1):63-74. PubMed ID: 19285755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nicotine effects on attentional reorienting in mid-age adults, and interactions with apolipoprotein E status.
    Evans S; Dowell NG; Tabet N; Tofts PS; King SL; Gray M; Rusted JM
    J Psychopharmacol; 2013 Nov; 27(11):1007-14. PubMed ID: 23958867
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between nicotine dependence and the endophenotype-related trait of cognitive function but not acoustic startle reponses in Japanese patients with schizophrenia.
    Kishi T; Fukuo Y; Okochi T; Kawashima K; Moriwaki M; Furukawa O; Musso GM; Fujita K; Correll CU; Iwata N
    Hum Psychopharmacol; 2013 May; 28(3):220-9. PubMed ID: 23553665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein E epsilon4 status and cognitive decline with and without dementia.
    Qiu C; Fratiglioni L
    Arch Neurol; 2010 Aug; 67(8):1036. PubMed ID: 20697064
    [No Abstract]   [Full Text] [Related]  

  • 51. Nicotinergic Modulation of Attention-Related Neural Activity Differentiates Polymorphisms of DRD2 and CHRNA4 Receptor Genes.
    Breckel TP; Giessing C; Gieseler A; Querbach S; Reuter M; Thiel CM
    PLoS One; 2015; 10(6):e0126460. PubMed ID: 26079805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APOE ε4 and Memory Among Patients With Heart Failure.
    Pressler SJ; Harrison JM; Titler M; Koelling TM; Jung M; Dorsey SG; Bakoyannis G; Riley PL; Hoyland-Domenico L; Giordani B
    West J Nurs Res; 2017 Apr; 39(4):455-472. PubMed ID: 27733670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking.
    Ahles TA; Li Y; McDonald BC; Schwartz GN; Kaufman PA; Tsongalis GJ; Moore JH; Saykin AJ
    Psychooncology; 2014 Dec; 23(12):1382-90. PubMed ID: 24789331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The nicotinic acetylcholine receptor gene CHRNA4 is associated with negative emotionality.
    Markett S; Montag C; Reuter M
    Emotion; 2011 Apr; 11(2):450-5. PubMed ID: 21500914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age-related memory decline and the APOE epsilon4 effect.
    Chuang JY
    N Engl J Med; 2009 Nov; 361(20):1996; author reply 1996-7. PubMed ID: 19907049
    [No Abstract]   [Full Text] [Related]  

  • 56. Combination of antioxidant supplements improved cognitive function in the elderly.
    Yasuno F; Tanimukai S; Sasaki M; Ikejima C; Yamashita F; Kodama C; Mizukami K; Asada T
    J Alzheimers Dis; 2012; 32(4):895-903. PubMed ID: 22886021
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Translocase of outer mitochondrial membrane 40 homolog (TOMM40) poly-T length modulates lorazepam-related cognitive toxicity in healthy APOE ε4-negative elderly.
    Pomara N; Bruno D; Sidtis JJ; Lutz MW; Greenblatt DJ; Saunders AM; Roses AD
    J Clin Psychopharmacol; 2011 Aug; 31(4):544-6. PubMed ID: 21720235
    [No Abstract]   [Full Text] [Related]  

  • 58. Are the effects of APOE ϵ4 on cognitive function in nonclinical populations age- and gender-dependent?
    Rusted J; Carare RO
    Neurodegener Dis Manag; 2015; 5(1):37-48. PubMed ID: 25711453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. APOE genotype and cognitive functioning in a large age-stratified population sample.
    Jorm AF; Mather KA; Butterworth P; Anstey KJ; Christensen H; Easteal S
    Neuropsychology; 2007 Jan; 21(1):1-8. PubMed ID: 17201525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Overdominant Effect of a
    Sadaghiani S; Ng B; Altmann A; Poline JB; Banaschewski T; Bokde ALW; Bromberg U; Büchel C; Burke Quinlan E; Conrod P; Desrivières S; Flor H; Frouin V; Garavan H; Gowland P; Gallinat J; Heinz A; Ittermann B; Martinot JL; Paillère Martinot ML; Lemaitre H; Nees F; Papadopoulos Orfanos D; Paus T; Poustka L; Millenet S; Fröhner JH; Smolka MN; Walter H; Whelan R; Schumann G; Napolioni V; Greicius M
    J Neurosci; 2017 Oct; 37(40):9657-9666. PubMed ID: 28877969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.